The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is a multicenter research study led by Yale that also includes Duke University, Boston Children’s Hospital, Children’s Hospital of Los Angeles , and the University of Washington/Seattle Children’s Research Institute. The aim of the consortium is to develop reliable and objective measurements of social function and communication in children on the autism spectrum.
What are the goals of the study?
The aim of the consortium is to develop reliable and objective measurements of social function and communication in children on the autism spectrum.
What will happen during the visit or online?
Caregivers will complete a screening phone call and questionnaires about their child. Children will complete in-person study visits at Boston Children’s Hospital over a 6 month period. Scheduling is flexible including weekends.
How will this help families?
Currently, ASD is diagnosed and treated based on information gathered from clinical assessments and parent questionnaires. ABC-CT will add to this pool of knowledge by developing a more objective battery of tools to measure social function.